Azithromycin, Singapore - Shim Clinic
Azithromycin
Latest News
Drug-resistance of gonorrhea in the EU: persistent but stableThu, 30 Aug 2018 11:00:00 +0800 | EurekAlert! - Infectious and Emerging Diseases
(European Centre for Disease Prevention and Control (ECDC)) Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP). This threatens the effectiveness of the currently recommended dual therapy regimen for gonorrhea. Overall, the rates of resistance to cefixime, ceftriaxone and azithromycin have remained stable when compared to recent years. (Source: EurekAlert! - Infectious and Emerging Diseases)
Zimbabwe:Drug Resistant Typhoid Is Real
Tue, 21 Aug 2018 15:12:12 +0800 | AllAfrica News: Health and Medicine
[The Herald] This strain of typhoid is not responding to traditionally used medicines such as ciprofloxacin and health workers have resorted to using the last line of antibiotics, azithromycin in defence against typhoid while waiting for approvals to embark on mass vaccinations. (Source: AllAfrica News: Health and Medicine)
FDA Warns Against Long - Term Azithromycin Use for Some
Tue, 14 Aug 2018 00:00:00 +0800 | The Doctors Lounge - Oncology
Warning for blood cancer patients who have undergone donor stem cell transplant (Source: The Doctors Lounge - Oncology)
FDA Warns Against Long-Term Azithromycin Use for Some
Mon, 13 Aug 2018 19:00:17 +0800 | Drugs.com - Pharma News
MONDAY, Aug. 13, 2018 -- The U.S. Food and Drug Administration is warning patients with cancers of the blood or lymph nodes who undergo a donor stem cell transplant not to take azithromycin, as long-term use of the antibiotic has been associated... (Source: Drugs.com - Pharma News)
FDA: Don't Use Azithromycin for Lung Condition in Cancer Patients FDA: Don't Use Azithromycin for Lung Condition in Cancer Patients
Fri, 03 Aug 2018 23:14:01 +0800 | Medscape Medical News Headlines
The FDA warns of an increased risk for relapse of hematologic malignancy and for death when azithromycin is used to prevent bronchiolitis obliterans syndrome in hematopoietic stem cell transplant patients.News Alerts (Source: Medscape Medical News Headlines)
FDA warns about increased risk of cancer relapse with long-term use of azithromycin (Zithromax, Zmax) antibiotic after donor stem cell transplant
Fri, 03 Aug 2018 19:21:00 +0800 | FDA Center for Drug Evaluation and Research - What's New
(Source: FDA Center for Drug Evaluation and Research - What's New)
Blood biomarker can help predict disease progression in patients with COPD
Thu, 12 Jul 2018 11:00:00 +0800 | EurekAlert! - Medicine and Health
(Elsevier) Some patients with COPD demonstrate signs of accelerated aging. In a new study published in the journal CHEST ® researchers report that measuring blood telomeres, a marker of aging of cells, can be used to predict future risk of the disease worsening or death. Further, they have determined that the drug azithromycin may help patients with short telomeres, an indicator of more rapid biological aging, stave off negative clinical outcomes. (Source: EurekAlert! - Medicine and Health)
Azithromycin Cuts Pulmonary Exacerbation in CF With Early Pa
Thu, 28 Jun 2018 02:00:47 +0800 | Drugs.com - Pharma News
WEDNESDAY, June 27, 2018 -- For children with cystic fibrosis (CF) and early Pseudomonas aeruginosa (Pa) infection, the risk of pulmonary exacerbation is significantly reduced with the addition of azithromycin to tobramycin inhalation solution... (Source: Drugs.com - Pharma News)
Pfizer announces extension of Zithromax ® Antibiotic Donation Program through 2025 to help eliminate world's leading infectious cause of blindness
Thu, 14 Jun 2018 15:00:00 +0800 | World Pharma News
Pfizer Inc. will extend its donation of the antibiotic Zithromax® (azithromycin) to the International Trachoma Initiative through 2025, building on the company's 20-years of work to help eliminate the world's leading infectious cause of blindness. Approximately 163 million people are at risk of developing the disease and this recommitment ensures that Pfizer, through the International Trachoma Initiative (ITI), will continue to provide trachoma endemic countries with donated antibiotics that are a critical component of the global strategy to eliminate this neglected tropical disease (NTD). (Source: World Pharma News)
Macrolide antibiotics for bronchiectasis
Fri, 01 Jun 2018 19:14:16 +0800 | Current Awareness Service for Health (CASH)
This Cochrane Review of 15 RCTs found that long-term macrolide therapy may reduce the frequency of exacerbations and improve quality of life, although supporting evidence is derived mainly from studies of azithromycin, and predominantly among adults rather than children. (Source: Current Awareness Service for Health (CASH))
